HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ONO 1301

a non-prostanoid prostaglandin I2 mimetic coumpound with inhibitory activity against thromboxane A2 synthase; structure given in first source
Also Known As:
(7,8-dihydro-5-((E)-((a-(3-pyridyl)benzylidene)aminooxy)ethyl)-1-naphthyloxy)acetic acid; ONO-1301
Networked: 27 relevant articles (12 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sakai, Yoshiki: 18 articles (12/2020 - 12/2005)
2. Miyagawa, Shigeru: 6 articles (02/2022 - 01/2013)
3. Sawa, Yoshiki: 6 articles (02/2022 - 01/2013)
4. Matsumoto, Kunio: 5 articles (01/2013 - 01/2012)
5. Fukushima, Satsuki: 4 articles (06/2019 - 01/2013)
6. Hirata, Yoichiro: 4 articles (01/2013 - 07/2009)
7. Sata, Masataka: 4 articles (01/2013 - 07/2009)
8. Nakayama, Mizuho: 3 articles (01/2013 - 01/2012)
9. Soeki, Takeshi: 3 articles (01/2013 - 12/2009)
10. Igarashi, Takashi: 3 articles (01/2012 - 07/2009)

Related Diseases

1. Fibrosis (Cirrhosis)
2. Ischemia
3. Pulmonary Hypertension
4. Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
5. Infarction (Infarctions)

Related Drugs and Biologics

1. Epoprostenol (Prostacyclin)
2. Thromboxanes
3. Monocrotaline
4. Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
5. Myosins (Myosin)
6. ONO 1301
7. Polyglactin 910
8. Therapeutic Uses
9. Neuroprotective Agents
10. Cytokines

Related Therapies and Procedures

1. Microspheres (Microsphere)
2. Subcutaneous Injections
3. Artificial Skin
4. Therapeutics